Comparison of the Angiotensin II Type 1-Receptor Antagonist YM358 and the Angiotensin-Converting Enzyme Inhibitor Enalapril in Rats With Cardiac Volume Overload-Reference-Cited by-同舟云学术

Comparison of the Angiotensin II Type 1-Receptor Antagonist YM358 and the Angiotensin-Converting Enzyme Inhibitor Enalapril in Rats With Cardiac Volume Overload

Published:2001 Issue:1 Volume:86 Page:79-85
ISSN:0021-5198
Container-title:Japanese Journal of Pharmacology
language:en
Short-container-title:Japanese Journal of Pharmacology

Author:

Tokioka-Akagi Tomoko,Fujimori Akira,Shibasaki Masayuki,Inagaki Osamu,Yanagisawa Isao

Publisher

Elsevier BV

Subject

Pharmacology

Reference21 articles.

1. What is the role of angiotensin-con-verting enzyme inhibitors in congestive heart failure and after myocardial infarction?;Nelson;Ann Pharmacother,1996

2. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE);Pitt;Lancet,1997

3. Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angio-tensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure [see comments];Cohn;J Card Fail,1999

4. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators [see comments];McKelvie;Circulation,1999

5. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II [see comments];Pitt;Lancet,2000

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resveratrol Arrests and Regresses the Development of Pressure Overload- but Not Volume Overload-Induced Cardiac Hypertrophy in Rats;The Journal of Nutrition;2010-03-24

2. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators;Life Sciences;2007-08

3. Hypertension;Wiley Handbook of Current and Emerging Drug Therapies;2006-10-13

4. Regulation of insulin-like growth factor-1 by the reninangiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist;Canadian Journal of Physiology and Pharmacology;2003-02-01

5. Angiotensin AT1/AT2 Receptors: Regulation, Signalling and Function;Blood Pressure;2003-01